中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 自动化研究所
  3. 中国科学院自动化研究所
  4. 脑图谱与类脑智能实验室
  5. 脑网络组研究中心
Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease

文献类型：期刊论文

作者Pan, Dan6; Zeng, An5; Yang, Baoyao5; Lai, Gangyong5; Hu, Bing4; Song, Xiaowei3; Jiang, Tianzi1,2
刊名ADVANCED SCIENCE
出版日期2022-12-27
页码19
关键词Alzheimer's disease deep learning longitudinal trajectories of neurodegeneration structural magnetic resonance imaging
DOI10.1002/advs.202204717
通讯作者Zeng, An(zengan@gdut.edu.cn) ; Yang, Baoyao(ybaoyao@gdut.edu.cn)
英文摘要Deep learning (DL) on brain magnetic resonance imaging (MRI) data has shown excellent performance in differentiating individuals with Alzheimer's disease (AD). However, the value of DL in detecting progressive structural MRI (sMRI) abnormalities linked to AD pathology has yet to be established. In this study, an interpretable DL algorithm named the Ensemble of 3-dimensional convolutional neural network (Ensemble 3DCNN) with enhanced parsing techniques is proposed to investigate the longitudinal trajectories of whole-brain sMRI changes denoting AD onset and progression. A set of 2369 T1-weighted images from the multi-centre Alzheimer's Disease Neuroimaging Initiative and Open Access Series of Imaging Studies cohorts are applied to model derivation, validation, testing, and pattern analysis. An Ensemble-3DCNN-based P-score is generated, based on which multiple brain regions, including amygdala, insular, parahippocampal, and temporal gyrus, exhibit early and connected progressive neurodegeneration. Complex individual variability in the sMRI is also observed. This study combining non-invasive sMRI and interpretable DL in detecting patterned sMRI changes confirmed AD pathological progression, shedding new light on predicting AD progression using whole-brain sMRI.
WOS关键词NEUROIMAGING BIOMARKERS ; ATROPHY ; HETEROGENEITY ; DECLINE ; INSULA ; CORTEX ; SCALE ; AGE
资助项目National Natural Science Foundation of China[61976058] ; National Natural Science Foundation of China[61772143] ; National Natural Science Foundation of China[62102098] ; Science and Technology Planning Project of Guangdong[2021A1515012300] ; Science and Technology Planning Project of Guangdong[2019A050510041] ; Science and Technology Planning Project of Guangdong[2021B0101220006] ; Science and Technology Planning Project of Guangzhou[202103000034] ; Science and Technology Planning Project of Guangzhou[202206010007] ; Science and Technology Planning Project of Guangzhou[202002020090] ; Science and Technology Planning Project of Guangzhou[202201010266] ; Science and Technology Planning Project of Guangzhou[FHG2017-001] ; Surrey Hospital and Outpatient Centre Foundation[FHG2017-001] ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)[U01 AG024904] ; DOD ADNI (Department of Defense Award[W81XWH-12-2-0012] ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; AbbVie ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; BioClinica, Inc. ; Biogen ; Bristol-Myers Squibb Company ; CereSpir, Inc. ; Cogstate; Eisai Inc. ; Elan Pharmaceuticals, Inc. ; Eli Lilly and Company ; EuroImmun ; F. Hoffmann-La Roche Ltd ; companyGenentech, Inc. ; Fujirebio ; GEHealthcare ; IXICO Ltd. ; Janssen Alzheimer Immunotherapy Research & Development, LLC. ; Johnson & Johnson Pharmaceutical Research & Development LLC. ; Lumosity ; Lundbeck ; Merck Co., Inc. ; Meso Scale Diagnostics, LLC. ; NeuroRx Research ; Neurotrack Technologies ; Novartis Pharmaceuticals Corporation ; Pfizer Inc. ; Piramal Imaging ; Servier ; Takeda Pharmaceutical Company ; Transition Therapeutics ; Canadian Institutes of Health Research
WOS研究方向Chemistry ; Science & Technology - Other Topics ; Materials Science
语种英语
出版者WILEY
WOS记录号WOS:000904760100001
资助机构National Natural Science Foundation of China ; Science and Technology Planning Project of Guangdong ; Science and Technology Planning Project of Guangzhou ; Surrey Hospital and Outpatient Centre Foundation ; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) ; DOD ADNI (Department of Defense Award ; National Institute on Aging ; National Institute of Biomedical Imaging and Bioengineering ; AbbVie ; Alzheimer's Association ; Alzheimer's Drug Discovery Foundation ; Araclon Biotech ; BioClinica, Inc. ; Biogen ; Bristol-Myers Squibb Company ; CereSpir, Inc. ; Cogstate; Eisai Inc. ; Elan Pharmaceuticals, Inc. ; Eli Lilly and Company ; EuroImmun ; F. Hoffmann-La Roche Ltd ; companyGenentech, Inc. ; Fujirebio ; GEHealthcare ; IXICO Ltd. ; Janssen Alzheimer Immunotherapy Research & Development, LLC. ; Johnson & Johnson Pharmaceutical Research & Development LLC. ; Lumosity ; Lundbeck ; Merck Co., Inc. ; Meso Scale Diagnostics, LLC. ; NeuroRx Research ; Neurotrack Technologies ; Novartis Pharmaceuticals Corporation ; Pfizer Inc. ; Piramal Imaging ; Servier ; Takeda Pharmaceutical Company ; Transition Therapeutics ; Canadian Institutes of Health Research
源URL[http://ir.ia.ac.cn/handle/173211/51150]  
专题自动化研究所_脑网络组研究中心
通讯作者Zeng, An; Yang, Baoyao
作者单位1.Chinese Acad Sci, Natl Lab Pattern Recognit, Inst Automat, Beijing 100190, Peoples R China
2.Chinese Acad Sci, Brainnetome Ctr, Inst Automat, Beijing 100190, Peoples R China
3.Fraser Hlth, Clin Res Ctr, Surrey Mem Hosp, Surrey, BC V3V 1Z2, Canada
4.Sun Yat Sen Univ, Dept Radiol, Affiliated Hosp 3, Guangzhou 510630, Peoples R China
5.Guangdong Univ Technol, Fac Comp, Guangzhou 510006, Peoples R China
6.Guangdong Polytech Normal Univ, Sch Elect & Informat, Guangzhou 510665, Peoples R China
推荐引用方式
GB/T 7714		 Pan, Dan,Zeng, An,Yang, Baoyao,et al. Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease[J]. ADVANCED SCIENCE,2022:19.
APA Pan, Dan.,Zeng, An.,Yang, Baoyao.,Lai, Gangyong.,Hu, Bing.,...&Jiang, Tianzi.(2022).Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease.ADVANCED SCIENCE,19.
MLA Pan, Dan,et al."Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease".ADVANCED SCIENCE (2022):19.

入库方式： OAI收割

来源：自动化研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。